Biopharmaceutical company Antylia Scientific is to create 60 jobs in Co Westmeath as it sets up a new facility in the National Science Park in Mullingar.

This is the company's first facility in Ireland and the project is supported by IDA Ireland.

The new jobs are in the areas of process and medical device engineering, manufacturing as well as logistics and supply chain.

Antylia Scientific's new bioprocessing facility will be used to design and manufacture Masterflex peristaltic technologies that are used in pharmaceutical and bioprocessing workflows for the development and production of vaccines and therapeutics.

The facility will also include a large warehouse space to store components and the finished products.

Brian Barnett, President of Masterflex Bioprocessing, said Antylia Scientific was thrilled to open its first facility in Ireland to produce and house Masterflex® peristaltic technologies and associated fluid path products.

These products are in great demand globally, according to Mr Barnett.

"The addition of this site to our Masterflex Bioprocessing family of global sites providing mission critical products and services will help the overall Biopharma industry. It is a win-win situation that will positively benefit our customers, our Masterflex brand, and the Mullingar workforce and economy," he added.

Martin Shanahan, the chief executive of IDA Ireland, said today's announcement by Antylia Scientific is a very positive one for the Midlands and is a strong endorsement in the region's talented and highly skilled biopharma and MedTech workforce.

"Antylia Scientific's significant investment in its Mullingar facility based at the National Science Park demonstrates the company's commitment to the Midlands region," he added.

The Minister for Trade Promotion, Digital and Company Regulation Robert Troy TD said today's news is a significant announcement for Mullingar and a strong endorsement of the Midlands as an excellent location for businesses to establish and thrive.

"Our highly skilled workforce is just one reason why Ireland is recognised as a global hub for leading biopharmaceutical companies like Antylia Scientific," he added.